Risk-adapted strategy or universal multimodal approach for PONV prophylaxis?

被引:26
|
作者
Kranke, Peter [1 ]
Meybohm, Patrick [1 ]
Diemunsch, Pierre [2 ]
Eberhart, Leopold H. J. [3 ]
机构
[1] Univ Hosp Wuerzburg, Dept Anaesthesia & Crit Care, Oberduerrbacher Str 6, D-97080 Wurzburg, Germany
[2] CHU Hautepierre, Serv Anesthesie Reanimat Chirurg, Strasbourg, France
[3] Philipps Univ Marburg, Dept Anaesthesiol & Intens Care, Marburg, Germany
关键词
postoperative nausea and vomiting; PONV; nausea; vomiting; antiemetics; patient satisfaction; anaesthesia; surgery; PREDICTING POSTOPERATIVE NAUSEA; CONSENSUS GUIDELINES; ANTIEMETIC PROPHYLAXIS; OUTPATIENT SURGERY; FACTORIAL TRIAL; 6; INTERVENTIONS; SCORE; ANESTHESIA; MANAGEMENT; PREVENTION;
D O I
10.1016/j.bpa.2020.05.003
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The issue of postoperative nausea and vomiting (PONV) remains important in surgical practice, contributing to patient distress, slower recovery, and increased use of healthcare resources. Many surgical patients report it to be a worse problem than pain. Numerous findings of research indicate that PONV significantly affects patients' well-being and is among the important determinants of patient satisfaction with perioperative care. Numerous investigations have confirmed the efficacy of combining pharmacological interventions indicating that PONV is a clinical complication that is in principle avoidable. Nonetheless, PONV continues to be bothersome for too many patients. Thus, perhaps the biggest challenge across the field is to achieve a uniformly high standard of PONV management using the currently available resources. Although a risk-adapted approach has been advocated in the past, the current trend incorporated in clinical guidelines support a more liberal approach of multimodal antiemetic prevention. The current article emphasizes pros and cons of the various approaches to PONV prophylaxis and depicts most promising strategies to achieve a "PONV-free hospital." (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页码:721 / 734
页数:14
相关论文
共 50 条
  • [1] Multimodal treatment of craniopharyngioma: Defining a risk-adapted strategy
    Puget, S
    Grill, J
    Habrand, JL
    Sainte-Rose, C
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2006, 19 : 367 - 370
  • [2] PONV after strabismus surgery. Risk adapted prophylaxis?
    Wolf, R.
    Morinello, E.
    Kestler, G.
    Kaesmann-Kellner, B.
    Bischoff, M.
    Hager, T.
    Schoepe, J.
    Eberhart, L. H. J.
    [J]. ANAESTHESIST, 2016, 65 (07): : 507 - 513
  • [3] RISK-ADAPTED ACCESS CONTROL WITH MULTIMODAL BIOMETRIC IDENTIFICATION
    Werner, Gabor
    Hanka, Laszlo
    [J]. INTERDISCIPLINARY DESCRIPTION OF COMPLEX SYSTEMS, 2020, 18 (03) : 327 - 336
  • [4] Radiation therapy in prostate cancer: a risk-adapted strategy
    Hayden, A. J.
    Catton, C.
    Pickles, T.
    [J]. CURRENT ONCOLOGY, 2010, 17 : S18 - S24
  • [5] Risk-adapted approach to prostate cancer screening
    Kirichek, A. A.
    Lyubchenko, L. N.
    Matveev, V. B.
    [J]. ONKOUROLOGIYA, 2018, 14 (02): : 109 - 121
  • [6] Risk-adapted multimodal laboratory cervical screening - Pap test of the future?
    Bollmann, R.
    Varnai, A. D.
    Bankfalvi, A.
    Bollmann, M.
    [J]. PATHOLOGE, 2007, 28 (05): : 334 - 338
  • [7] Risk-adapted strategy for the management of febrile neutropenia in cancer patients
    Jean Klastersky
    Marianne Paesmans
    [J]. Supportive Care in Cancer, 2007, 15 : 477 - 482
  • [8] Risk-adapted strategy for the management of febrile neutropenia in cancer patients
    Klastersky, Jean
    Paesmans, Marianne
    [J]. SUPPORTIVE CARE IN CANCER, 2007, 15 (05) : 477 - 482
  • [9] Myelodysplastic syndromes: toward a risk-adapted treatment approach
    Faltas, Bishoy
    Zeidan, Amer
    Gergis, Usama
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (05) : 611 - 624
  • [10] Follicular lymphoma: are we ready for a risk-adapted approach?
    Kahl, Brad S.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 358 - 364